CPD functions as an integral component of the Education Office at the Schulich School of Medicine & Dentistry, Western University and provides accredited CME programs for practicing healthcare providers in Southwestern Ontario and nationally. CPD has been assessed against a defined set of accreditation standards and has been accredited by the Committee on Accreditation of Continuing Medical Education (CACME).
As an accredited continuing education provider, CPD is responsible for ensuring that every course that it develops or approves as an accredited program, adheres to the guidelines and standards, established by its governing external and internal regulatory and advisory bodies.
Target Audience: Oncologists
Accreditation: RCPSC Maincert Section 3
Duration: up to 1 hour
About this program
Our specialist modules provide an easy-to-use report on the most recent clinical advances in the management of metastatic melanoma and the associated side-effects of therapy. This offering is divided into two modules, one dealing with targeted therapies, the other with immune-checkpoint inhibitors. Participants will undergo a pre- and post-test and will receive a detailed score card with peer group comparison.
This is a 0.75 hour Maincert Section 3 Accredited Self-Assessment program designed to help health care providers recognize common side effects with targeted therapies and identify how best to alter therapy to improve patient outcomes.
This is a 0.75 hour Maincert Section 3 Accredited Self-Assessment program designed to help health care providers recognize common side effects with immune-checkpoint inhibitors and identify how best to alter therapy to improve patient outcomes.
Il s'agit d'un programme d'auto-évaluation de Maincert Section 3 d'une heure destiné aux chirurgiens intéressés par des recherches récentes mettant en évidence la valeur pronostique de la biopsie du ganglion sentinelle et de nouvelles preuves sur l'intérêt de la lymphadénectomie totale pour la survie du patient.